(BRK.A), (BRK.B)
Berkshire Hathaway has completed the acquisition of OxyChem from Occidental Petroleum in a deal valued at $9.7 billion, subject to customary post-closing purchase price adjustments. The transaction brings one of North America’s leading chemical producers into Berkshire Hathaway’s portfolio.
Headquartered in Dallas, Texas, OxyChem operates across the United States, Canada, and Latin America and is a top-three U.S. manufacturer of polyvinyl chloride (PVC), chlor-alkali products, chlorinated organic chemicals, and calcium chloride. The company produces essential chemicals used in a wide range of everyday and industrial applications, including water treatment, pharmaceuticals, healthcare, manufacturing, automotive production, personal hygiene products, and residential and commercial construction.
Following the acquisition, OxyChem will continue to operate under its existing leadership. Wade Alleman will remain president and CEO, ensuring continuity in management and strategy as the company moves forward under Berkshire Hathaway’s ownership.
© 2026 David Mazor
Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.